Rating Change
RBC Capital reiterated its Outperform rating on Colgate-Palmolive Company (NYSE:CL) on November 02, 2026.
reiterateNYSE:CL
RBC Capital Reiterates Outperform Rating on Colgate-Palmolive Company (CL)
RBC Capital reiterated its Outperform rating on Colgate-Palmolive Company (NYSE:CL) on November 02, 2026.
At publication ·
What changed
Colgate-Palmolive Company (NYSE:CL) · reiterate
- Firm
- RBC Capital
- Rating
- Outperform to Outperform
- Price at event
- $97.43
- Market capitalization
- $62.3B
At a glance
Key takeaways
- RBC Capital reiterated an Outperform rating on Colgate-Palmolive on November 2, 2026, with the stock trading at $97.43 and a market cap of $62.3 billion.
Market Context
Colgate-Palmolive Company operates in the Consumer Defensive sector. The stock currently trades at $97.43 with a market capitalization of $62.3B. The stock has gained 26.4% over the past 52 weeks.
Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Colgate-Palmolive Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Colgate-Palmolive Company
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 02, 2026 | RBC Capital | Outperform | N/A |
| Nov 02, 2026 | JP Morgan | Overweight | N/A |
| Nov 02, 2026 | TD Cowen | Hold | N/A |
| Nov 02, 2026 | BNP Paribas | Outperform | N/A |
| Nov 02, 2026 | Morgan Stanley | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View CL Stock Page
Frequently Asked Questions
What does the Outperform rating mean for CL?
A rating of Outperform from RBC Capital reflects the analyst's outlook on Colgate-Palmolive Company (NYSE:CL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CL forecast page.
